AR127856A1 - PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE - Google Patents
PROCESS FOR THE PREPARATION OF TEMOZOLOMIDEInfo
- Publication number
- AR127856A1 AR127856A1 ARP220103318A ARP220103318A AR127856A1 AR 127856 A1 AR127856 A1 AR 127856A1 AR P220103318 A ARP220103318 A AR P220103318A AR P220103318 A ARP220103318 A AR P220103318A AR 127856 A1 AR127856 A1 AR 127856A1
- Authority
- AR
- Argentina
- Prior art keywords
- temozolomide
- preparation
- nmci
- relates
- present
- Prior art date
Links
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 229960004964 temozolomide Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- UIKPUVLIJJJXNA-UHFFFAOYSA-N 1-methylimidazole-2-carboxamide Chemical compound CN1C=CN=C1C(N)=O UIKPUVLIJJJXNA-UHFFFAOYSA-N 0.000 abstract 1
- 210000005097 arteria cerebelosa anteroinferior Anatomy 0.000 abstract 1
- 238000004440 column chromatography Methods 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención se refiere a un proceso para la preparación de temozolomida a gran escala industrial que usa N-metil carbamoilimidazol (NMCI) Forma I en la preparación del intermedio clave 5-amino-N1-imidazol-1,4-dicarboxamida (carbamoil-AICA). Además, la presente invención se refiere a un proceso para preparar NMCI Forma I. La NMCI Forma I y la temozolomida se purifican por cristalización, sin emplear cromatografía en columna o extracción continua.The present invention relates to a process for the preparation of temozolomide on a large industrial scale using N-methyl carbamoylimidazole (NMCI) Form I in the preparation of the key intermediate 5-amino-N1-imidazole-1,4-dicarboxamide (carbamoyl- AICA). Furthermore, the present invention relates to a process for preparing NMCI Form I. NMCI Form I and temozolomide are purified by crystallization, without employing column chromatography or continuous extraction.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102021024662-6A BR102021024662A2 (en) | 2021-12-06 | PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE |
Publications (1)
Publication Number | Publication Date |
---|---|
AR127856A1 true AR127856A1 (en) | 2024-03-06 |
Family
ID=86729337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP220103318A AR127856A1 (en) | 2021-12-06 | 2022-12-02 | PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN118355018A (en) |
AR (1) | AR127856A1 (en) |
WO (1) | WO2023102627A1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8258294B2 (en) * | 2006-09-29 | 2012-09-04 | Cipla Limited | Process for the preparation of temozolomide and analogs |
EP2151442A3 (en) * | 2008-08-07 | 2011-04-06 | Chemi SPA | Process for preparing temozolomide |
WO2010140168A1 (en) * | 2009-06-03 | 2010-12-09 | Ind-Swift Laboratories Limited | Improved process for preparing temozolomide |
WO2015057585A1 (en) * | 2013-10-14 | 2015-04-23 | Regents Of The University Of Minnesota | Therapeutic compounds |
WO2018112589A1 (en) * | 2016-12-20 | 2018-06-28 | Cristália Produtos Químicos Farmacêuticos Ltda | Process for preparing temozolomide and an intermediary |
WO2018122724A1 (en) * | 2016-12-27 | 2018-07-05 | Granules India Limited | Temozolomide process |
WO2020194168A1 (en) * | 2019-03-25 | 2020-10-01 | Shivalik Rasayan Limited | Process for preparing highly pure temozolomide |
-
2022
- 2022-12-02 AR ARP220103318A patent/AR127856A1/en unknown
- 2022-12-05 WO PCT/BR2022/050478 patent/WO2023102627A1/en unknown
- 2022-12-05 CN CN202280080902.3A patent/CN118355018A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2023102627A1 (en) | 2023-06-15 |
CN118355018A (en) | 2024-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018006606A (en) | Method of producing high purity d-psicose. | |
MX2020004844A (en) | Process for purification of a neutral human milk oligosaccharide using simulated moving bed chromatography. | |
BR112018075433A2 (en) | piperidinyl derivatives, processes for their preparation and pharmaceutical compositions containing them | |
MY191504A (en) | Urea production process and plant | |
BR112017020153A8 (en) | MICROSTRUCTURED CARBONATABLE CALCIUM SILICATE SLAG AND METHODS THEREOF | |
BRPI0519624B8 (en) | process for preparing purified ansamitocins | |
BR112012019032A2 (en) | "process for ethanol purification" | |
DE502006001608D1 (en) | Process and installation for concentrating waste sulfuric acids from nitriding processes | |
AR104505A1 (en) | SOLID FORMS | |
CL2018001720A1 (en) | Crystalline polymorphic forms of obetolic acid | |
MX171141B (en) | PROCEDURE TO PURIFY THE EFFLUENT WATER OF THE FACILITIES TO MANUFACTURE UREA | |
JP2013538677A5 (en) | ||
ECSP18054047A (en) | MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A, and IL-17F | |
CO2017010720A2 (en) | Process to isolate and purify ambrox | |
AR127856A1 (en) | PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE | |
BR112017000090A2 (en) | Method for removing dinitrotoluene impurities | |
AR087806A1 (en) | PROCESS TO PURIFY A JET THAT INCLUDES 1,4-BUTANODIOL | |
BRPI0515695A (en) | process for isolation of crystalline tacrolimus | |
BR112019007441A2 (en) | method for purification of 4-hydroxyacetophenone | |
WO2018153381A9 (en) | High-purity isothiocyanate compound preparation method for industrial production | |
CU20120163A7 (en) | AGOMELATIN INTERMEDIATES AND METHOD OF PREPARATION OF THESE | |
AR098610A1 (en) | PROCESS FOR THE PRODUCTION OF DIALQUIL SUCCINATE | |
BR112018015689A2 (en) | method of producing high purity monochloric acid | |
ITMI20051085A1 (en) | METHOD OF PURIFICATION OF CEFOTETAN | |
BR112017017640A2 (en) | esterification process of a diol using a reactive distillation |